As a GLP-1 receptor agonist and GIP receptor agonist, it works by enhancing insulin sensitivity, reducing blood sugar levels, and increasing feelings of fullness, which contributes to weight loss
Despite increased investments by Lilly and Novo to boost production, shortages continue, especially for the lower starter doses of Wegovy, which the FDA still lists as being in shortage
However, the modest effect does not negate the potential value of these drugs, especially for conditions where few effective treatment options exist, for example, dementia, Al-Aly said
Cancer typically develops over many years, and trial durations of 12 years may be insufficient to detect slowly developing malignancies
Dose reduction after reaching goal weight Once you reach your target weight, many prescribers reduce the dose rather than stopping abruptly
Then, liver tissues were cut at 70 nm thickness using ultramicrotome (Leica UC7, Leica), and next stained with uranyl acetate and lead solution